shareholder rights

ePlus faces securities fraud investigation after missing Q3 2025 earnings and stock drops 13.1%. Law firm seeks investors to join class action lawsuit.

Schall Law Firm seeks lead plaintiffs in class action against $QURE for alleged false statements regarding FDA approval timeline and BLA submission misrepresentations.

Paysafe faces securities fraud lawsuit alleging false risk disclosures and understated credit reserves. Law firm seeks lead plaintiffs from investors during March-November 2025 period.

Schall Law Firm investigates $WMK for securities violations following disclosure of overstated inventory requiring financial restatements and delayed 10-K filing.

Schall Law Firm investigates Priority Technology Holdings for potential fiduciary duty breaches, seeking NASDAQ-listed shareholders to join class action lawsuit.

Rosen Law Firm investigates Hitek Global ($HKIT) over alleged materially misleading disclosures; shareholders encouraged to join potential class action lawsuit to recover losses.

Schall Law Firm launches class action against $COTY for allegedly making false statements about fiscal 2026 growth prospects while Consumer Beauty segment underperformed.

Rosen Law Firm investigates $CHSN for allegedly issuing materially misleading business information, preparing class action lawsuit to recover investor losses.

Schall Law Firm seeks $PSIX investors for class action over alleged false statements on data center business and manufacturing costs. Deadline: May 19, 2026.

Schall Law Firm seeks investors in $LU securities lawsuit, alleging Lufax made false statements and failed internal controls between April 2023 and January 2025.

SES AI faces securities investigation after stock plunged 36.8% following March 4 earnings, allegedly due to undisclosed $1.5M shipment delays.

Halper Sadeh investigates whether $SEM, $FONR, $NWE shareholders receive fair deal terms in proposed transactions amid fiduciary duty concerns.

UniQure faces securities fraud lawsuit alleging false FDA approval and BLA timeline claims. Investors in stock between September-October 2025 can join class action by April 2026 deadline.

Schall Law Firm seeks $PSFE investors from March-November 2025 in class action alleging securities fraud tied to understated credit risks.

The Schall Law Firm investigates Neumora Therapeutics ($NMRA) for potential securities fraud involving false statements or material information omissions.

Class actions filed against $PYPL over false revenue projections and $RGENX after FDA clinical hold on gene therapy following safety concerns.

Schall Law Firm launches securities fraud lawsuit against Alight ($ALIT) for alleged misstatements on operations and dividends; investors urged to join by May 15, 2026.

Schall Law Firm files securities fraud class action against $MNDY for allegedly misrepresenting revenue outlook and customer growth prospects.

Johnson Fistel investigates Lifecore Biomedical over 15-18% revenue miss and 18% stock decline, offering shareholder recovery options for alleged securities law violations.

Eos Energy Enterprises faces securities fraud class action over alleged false production and capacity disclosures from November 2025 to February 2026.